Treatment-related outcome of oropharyngeal cancer patients differentiated by HPV dictated risk profile: a tertiary cancer centre series analysis.
about
The current and future impact of human papillomavirus on treatment of squamous cell carcinoma of the head and neckHeterogeneity of (18)F-FDG PET combined with expression of EGFR may improve the prognostic stratification of advanced oropharyngeal carcinoma.The rationale for HPV-related oropharyngeal cancer de-escalation treatment strategiesMeta-analysis of survival in patients with HNSCC discriminates risk depending on combined HPV and p16 status.The prevalence of human papillomavirus in squamous cell carcinoma of unknown primary site metastatic to neck lymph nodes: a systematic review.Primary treatment for oropharyngeal squamous cell carcinoma in Alberta, Canada: A population-based study.Oncolytic activity of reovirus in HPV positive and negative head and neck squamous cell carcinomaHuman papillomavirus association is the most important predictor for surgically treated patients with oropharyngeal cancer.Meta analysis: HPV and p16 pattern determines survival in patients with HNSCC and identifies potential new biologic subtype.The evolution of the epidemiological landscape of head and neck cancer in Italy: Is there evidence for an increase in the incidence of potentially HPV-related carcinomas?High-throughput testing in head and neck squamous cell carcinoma identifies agents with preferential activity in human papillomavirus-positive or negative cell lines.Comparison of PI3K Pathway in HPV-Associated Oropharyngeal Cancer With and Without Tobacco Exposure
P2860
Q26830495-E2AD029D-3A58-4784-A89F-122FE07CFD17Q35756750-D861A66D-C084-4DA5-AE10-AB0FF1F4A947Q35838231-8DFF3EA6-A1A4-4962-A99F-EB3F087FFD7FQ38557897-B05DCFC7-6981-40DC-A63C-C41FD403AC03Q38584576-FF0691BA-06F6-4680-A593-ACD8045B1865Q38637666-EC95052F-E693-490E-A932-9CD7E74B26ACQ38885144-33E0C7F5-BB20-411F-9CC7-15FAAC795E99Q40214883-E1130CFC-CBE0-4736-88B9-3A06448F1AF5Q47106465-CE4B99A4-0293-4B1D-BED0-67A696FE759EQ50133379-4DC2F5C5-78EF-4A93-9F47-D8E6CEE7B739Q55027478-6112D16D-F5A8-4136-B240-3A444EE5A013Q58792602-724FB656-61FD-468F-A985-CB13800850A8
P2860
Treatment-related outcome of oropharyngeal cancer patients differentiated by HPV dictated risk profile: a tertiary cancer centre series analysis.
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Treatment-related outcome of o ...... cancer centre series analysis.
@ast
Treatment-related outcome of o ...... cancer centre series analysis.
@en
type
label
Treatment-related outcome of o ...... cancer centre series analysis.
@ast
Treatment-related outcome of o ...... cancer centre series analysis.
@en
prefLabel
Treatment-related outcome of o ...... cancer centre series analysis.
@ast
Treatment-related outcome of o ...... cancer centre series analysis.
@en
P2093
P2860
P50
P356
P1433
P1476
Treatment-related outcome of o ...... cancer centre series analysis
@en
P2093
B Cortelazzi
G Scaramellini
P2860
P304
P356
10.1093/ANNONC/MDU004
P50
P577
2014-02-07T00:00:00Z